The global market for nicotine replacement therapies (NRTs) is experiencing significant growth, with projections reaching $7.52 billion by 2032. This expansion is fueled by increasing awareness of health issues related to smoking and advancements in personalized NRT options.
Innovative products like new nicotine gums and tailored therapies are making quitting smoking more accessible and effective, contributing to public health efforts worldwide.